Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Paul R. Kalra, John G.F. Cleland, Mark C. Petrie, Elizabeth A. Thomson, Philip A. Kalra, Iain B. Squire, Fozia Z. Ahmed, Abdallah Al-Mohammad, Peter J. Cowburn, Paul W.X. Foley, Fraser J. Graham, Alan G. Japp, Rebecca E. Lane, Ninian N. Lang, Andrew J. Ludman, Iain C. Macdougall, Pierpaolo Pellicori, Robin Ray, Michele Robertson, Alison SeedIan Ford (Lead / Corresponding author), IRONMAN Study Group

Research output: Contribution to journalArticlepeer-review

251 Citations (Scopus)
91 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science